RTI Consulting

RTI Bio is a US-based, private consultancy founded in 2008, offering high-value strategic advisory services to the biopharmaceutical industry. Its core offerings are divided into three pillars: CMC management for drug developers, implementation strategy for bioprocess technology companies, and technical due diligence for investors. The firm's value proposition is rooted in the extensive, 35+ year industry experience of its principal, leveraging a network built from prior roles in leading consulting firms and biotech companies to guide clients through complex development and commercialization challenges.

The firm's platform is the integrated expertise and methodological consulting approach of its founder in CMC strategy, bioprocess development, and biopharma commercialization.

RTI Bio competes with large professional services firms (e.g., BDO, PwC) that have life science consulting arms, as well as other boutique CMC and bioprocess consulting firms. Its differentiation is the highly specific, senior-level expertise and hands-on operational experience of its principal, offering a personalized alternative to larger, more generalized teams.